Skip to main content
See every side of every news story
Published loading...Updated

Ozempic Cleared For Use in India: Pros, Cons, and Expected Pricing

Summary by BreezyScroll
India’s drug regulator has cleared Ozempic (semaglutide), a once-weekly injectable treatment for Type-2 diabetes, opening doors to a therapy that has transformed diabetes care worldwide and sparked a global weight-loss craze. The approval marks a milestone in India’s fight against lifestyle-related diseases but also raises questions about affordability, risks, and long-term impact. What is Ozempic and how does it work? Ozempic, developed by Dani…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

BreezyScroll broke the news in on Thursday, October 2, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal